WATCHMANTM LAAC in Practice: From Clinical Evidence to Real-World Execution
Episode 1: The Evidence Base for LAAC: What Matters Most

Date
Thursday, July 30, 2026
 
Time
7:00 PM (UTC-04:00) Eastern Time (US & Canada)
 
Duration
60 minutes
 
Description

Explore the most important clinical evidence shaping left atrial appendage closure (LAAC), with a focused look at the data that matters most for shared decision making. This session distills key trials and outcomes to help clinicians confidently evaluate the role of LAAC in stroke risk reduction. Gain practical insight into how the evidence translates into real-world patient selection and care. 

 

This is a non-CME event. By registering for this program, you consent to share your registration information with the program's sponsor.

 

 

©️2026 Boston Scientific Corporation or its affiliates. All rights reserved. All trademarks are property of their respective owners. Rx only. SH-2531410-AA​

Sponsored by:

Boston Scientific

Speakers

Matthew Sherwood, MD, MHS
Matthew Sherwood, MD, MHS
System Director for Interventional Cardiology and Co-Director of Inova’s
Structural Heart Disease Program

Christopher Ellis, MD, FACC, FHRS
Christopher Ellis, MD, FACC, FHRS
Professor of Medicine, Director LAA Closure Program and Atrial Fibrillation Center
Vanderbilt Heart and Vascular Institute

Matthew Price, MD
Matthew Price, MD
Professor of Medicine, Director of the Cardiac Catheterization Laboratory
Scripps Clinic